ALYSSA BIJEAUX: Open Payments
NPI 1992396089 · OAKDALE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 11 payments from 7 companies in 2025. Trend: 2023 $83 · 2024 $97 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 5 | $196 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Qelbree, UZEDY, FANAPT, Jornay PM, Auvelity, CAPLYTA.
Industry payments across LA — which companies pay providers there.
